Tucker Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Tucker Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100	Closed	-$3.84K	–	1591
2023 Q2	$3.84K	Hold	100	–	–	﹤0.01%	736
2023 Q1	$2.31K	Buy	+100	New	+$2.38K	﹤0.01%	866

Tucker Asset Management's KDNY Position: Q3 2023 in Review

Tucker Asset Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 100 shares — an estimated $3.84K sold.

Tucker Asset Management first reported a position in KDNY in Q1 2023 and held it in 2 quarters. The position peaked at $3.84K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Tucker Asset Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Tucker Asset Management sold 100 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $3.84K.
Tucker Asset Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Tucker Asset Management's Chinook Therapeutics, Inc. Common Stock position peaked at $3.84K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Tucker Asset Management's 13F filing for Q3 2023, filed 4 Dec 2023.